LEX-WK-HNEQ9VGVcrawled 2025-02-17 02:17Z
MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?
Grant Castle · Sarah Cowlishaw · Marie Doyle-Rossi · Raj Gathani · Dan Spivey · Mark Mitchell · Inside EU Life Sciences · Published February 12, 2025
Work details
- author
- Grant Castle · Sarah Cowlishaw · Marie Doyle-Rossi · Raj Gathani · Dan Spivey · Mark Mitchell
- firm or organization
- Covington & Burling LLP
- publication
- Inside EU Life Sciences
- practice area
- Health Care and Life Sciences
- published
- 2025-02-12
Citation
Grant Castle, Sarah Cowlishaw, Marie Doyle-Rossi, Raj Gathani, Dan Spivey, Mark Mitchell, MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?, Inside EU Life Sciences (February 12, 2025) [The Library at LexBlog, LEX-WK-HNEQ9VGV, lexpid.org/HNEQ9VGV]